Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 6 studies | 17% ± 1% | |
ciliated cell | 6 studies | 26% ± 11% | |
CD4-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 4 studies | 19% ± 2% | |
naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 19% ± 3% | |
B cell | 4 studies | 17% ± 2% | |
CD8-positive, alpha-beta T cell | 4 studies | 18% ± 2% | |
gamma-delta T cell | 3 studies | 25% ± 8% | |
epithelial cell | 3 studies | 34% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 4 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 207.37 | 2639 / 2642 | 99% | 3.13 | 700 / 705 |
thymus | 100% | 167.02 | 653 / 653 | 99% | 3.21 | 599 / 605 |
prostate | 100% | 142.15 | 244 / 245 | 98% | 2.06 | 494 / 502 |
uterus | 100% | 113.51 | 170 / 170 | 93% | 1.97 | 428 / 459 |
adrenal gland | 100% | 215.33 | 258 / 258 | 93% | 2.14 | 214 / 230 |
breast | 100% | 133.08 | 458 / 459 | 92% | 1.86 | 1029 / 1118 |
kidney | 100% | 196.94 | 89 / 89 | 88% | 1.62 | 796 / 901 |
lung | 99% | 130.49 | 573 / 578 | 87% | 1.69 | 1007 / 1155 |
bladder | 100% | 123.90 | 21 / 21 | 83% | 1.63 | 420 / 504 |
pancreas | 100% | 95.61 | 327 / 328 | 83% | 1.51 | 147 / 178 |
ovary | 99% | 111.08 | 179 / 180 | 80% | 1.48 | 342 / 430 |
stomach | 100% | 121.18 | 359 / 359 | 75% | 1.20 | 214 / 286 |
intestine | 100% | 133.35 | 966 / 966 | 75% | 1.26 | 394 / 527 |
skin | 100% | 130.17 | 1805 / 1809 | 75% | 1.35 | 353 / 472 |
esophagus | 100% | 121.49 | 1443 / 1445 | 66% | 1.09 | 120 / 183 |
liver | 93% | 58.90 | 210 / 226 | 63% | 1.02 | 254 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.17 | 29 / 29 |
spleen | 100% | 221.50 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.73 | 1 / 1 |
adipose | 100% | 122.82 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 133.49 | 1325 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 140.68 | 795 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 190.55 | 917 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 125.70 | 849 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 1.55 | 38 / 45 |
eye | 0% | 0 | 0 / 0 | 68% | 1.03 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016020 | Cellular component | membrane |
Gene name | SMIM27 |
Protein name | Small integral membrane protein 27 (TOPORS antisense RNA 1) HCG1811779, isoform CRA_a (Small integral membrane protein 27) Small integral membrane protein 27 |
Synonyms | hCG_1811779 TOPORS-AS1 C9orf133 |
Description | |
Accessions | ENST00000450093 A0A286YEC1 A0A1B0GW09 ENST00000450093.3 A0A1B0GUW7 ENST00000692500.1 A0A1B0GV65 ENST00000644531.1 A0A2R8Y3B0 A0A1W2PRY6 ENST00000425533.1 ENST00000635960.1 ENST00000453396.5 ENST00000451672.2 |